Fig. 3From: Prognostic impact of 18F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancerDisease-free survival in patients with higher SUVpeak subgroup and higher TLR subgroupBack to article page